adamantane has been researched along with Hemorrhagic Fever, Ebola in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chaudhari, HK; Mali, SN | 1 |
Bruchez, A; Chandran, K; Côté, M; Cunningham, J; Filone, CM; Hensley, L; Lee, K; Li, Q; Misasi, J; Ory, D; Ren, T | 1 |
2 other study(ies) available for adamantane and Hemorrhagic Fever, Ebola
Article | Year |
---|---|
Molecular modelling studies on adamantane-based Ebola virus GP-1 inhibitors using docking, pharmacophore and 3D-QSAR.
Topics: Adamantane; Drug Design; Ebolavirus; Hemorrhagic Fever, Ebola; Models, Molecular; Molecular Docking Simulation; Quantitative Structure-Activity Relationship | 2019 |
Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection.
Topics: Adamantane; Animals; Antiviral Agents; Carrier Proteins; Cathepsins; Cell Line; Chlorocebus aethiops; Ebolavirus; Endosomes; Glycoproteins; Hemorrhagic Fever, Ebola; Humans; Intracellular Signaling Peptides and Proteins; Membrane Fusion; Membrane Glycoproteins; Molecular Weight; Niemann-Pick C1 Protein; Piperazines; Vero Cells; Viral Fusion Proteins; Virus Internalization | 2011 |